Expand BLTE Menu
BLTE MENU

BLTE Latest Press Releases

-- April 23, 2026 --

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026 Globe Newswire 8:35 AM
Belite Bio to Participate in Four Upcoming Investor Conferences Globe Newswire 8:00 AM

-- April 22, 2026 --

Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th Globe Newswire 8:35 AM

-- April 21, 2026 --

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Globe Newswire 4:00 PM

-- March 31, 2026 --

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website Globe Newswire 8:00 AM

-- March 2, 2026 --

Belite Bio to Participate in the Leerink Global Healthcare Conference Globe Newswire 8:00 AM
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 6:00 AM

-- February 23, 2026 --

Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 8:00 AM

-- January 29, 2026 --

Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO) Globe Newswire 8:00 AM

-- January 27, 2026 --

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1) Globe Newswire 8:00 AM

-- December 1, 2025 --

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares Globe Newswire 10:37 PM
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares Globe Newswire 4:20 PM
New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes